Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH

Jie Sun, Xue Qiao Zhao, Niranjan Balu, Moni B. Neradilek, Daniel A. Isquith, Kiyofumi Yamada, Gádor Cantón, John R. Crouse, Todd J. Anderson, John Huston, Kevin O'Brien, Daniel S. Hippe, Nayak L. Polissar, Chun Yuan, Thomas S. Hatsukami

Research output: Contribution to journalArticle

42 Scopus citations

Abstract

Objectives The aim of this study was to investigate whether and what carotid plaque characteristics predict systemic cardiovascular outcomes in patients with clinically established atherosclerotic disease. Background Advancements in atherosclerosis imaging have allowed assessment of various plaque characteristics, some of which are more directly linked to the pathogenesis of acute cardiovascular events compared to plaque burden. Methods As part of the event-driven clinical trial AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides: Impact on Global Health Outcomes), subjects with clinically established atherosclerotic disease underwent multicontrast carotid magnetic resonance imaging (MRI) to detect plaque tissue composition and high-risk features. Prospective associations between MRI measurements and the AIM-HIGH primary endpoint (fatal and nonfatal myocardial infarction, ischemic stroke, hospitalization for acute coronary syndrome, and symptom-driven revascularization) were analyzed using Cox proportional hazards survival models. Results Of the 232 subjects recruited, 214 (92.2%) with diagnostic image quality constituted the study population (82% male, mean age 61 ± 9 years, 94% statin use). During median follow-up of 35.1 months, 18 subjects (8.4%) reached the AIM-HIGH endpoint. High lipid content (hazard ratio [HR] per 1 SD increase in percent lipid core volume: 1.57; p = 0.002) and thin/ruptured fibrous cap (HR: 4.31; p = 0.003) in carotid plaques were strongly associated with the AIM-HIGH endpoint. Intraplaque hemorrhage had a low prevalence (8%) and was marginally associated with the AIM-HIGH endpoint (HR: 3.00; p = 0.053). High calcification content (HR per 1 SD increase in percent calcification volume: 0.66; p = 0.20), plaque burden metrics, and clinical risk factors were not significantly associated with the AIM-HIGH endpoint. The associations between carotid plaque characteristics and the AIM-HIGH endpoint changed little after adjusting for clinical risk factors, plaque burden, or AIM-HIGH randomized treatment assignment. Conclusions Among patients with clinically established atherosclerotic disease, carotid plaque lipid content and fibrous cap status were strongly associated with systemic cardiovascular outcomes. Markers of carotid plaque vulnerability may serve as novel surrogate markers for systemic atherothrombotic risk.

Original languageEnglish (US)
Pages (from-to)241-249
Number of pages9
JournalJACC: Cardiovascular Imaging
Volume10
Issue number3
DOIs
StatePublished - Mar 1 2017

Keywords

  • atherosclerosis
  • cardiovascular events
  • carotid artery
  • magnetic resonance imaging
  • surrogate marker
  • vulnerable plaque

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH'. Together they form a unique fingerprint.

  • Cite this

    Sun, J., Zhao, X. Q., Balu, N., Neradilek, M. B., Isquith, D. A., Yamada, K., Cantón, G., Crouse, J. R., Anderson, T. J., Huston, J., O'Brien, K., Hippe, D. S., Polissar, N. L., Yuan, C., & Hatsukami, T. S. (2017). Carotid Plaque Lipid Content and Fibrous Cap Status Predict Systemic CV Outcomes: The MRI Substudy in AIM-HIGH. JACC: Cardiovascular Imaging, 10(3), 241-249. https://doi.org/10.1016/j.jcmg.2016.06.017